KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Gross Margin (2016 - 2025)

Evolent Health has reported Gross Margin over the past 11 years, most recently at 20.75% for Q4 2025.

  • Quarterly results put Gross Margin at 20.75% for Q4 2025, up 904.0% from a year ago — trailing twelve months through Dec 2025 was 21.31% (up 693.0% YoY), and the annual figure for FY2025 was 21.31%, up 693.0%.
  • Gross Margin for Q4 2025 was 20.75% at Evolent Health, roughly flat from 20.81% in the prior quarter.
  • Over the last five years, Gross Margin for EVH hit a ceiling of 33.77% in Q4 2021 and a floor of 11.71% in Q4 2024.
  • Median Gross Margin over the past 5 years was 22.22% (2021), compared with a mean of 22.07%.
  • Biggest five-year swings in Gross Margin: plummeted -1205bps in 2022 and later skyrocketed 904bps in 2025.
  • Evolent Health's Gross Margin stood at 33.77% in 2021, then tumbled by -36bps to 21.72% in 2022, then dropped by -16bps to 18.28% in 2023, then crashed by -36bps to 11.71% in 2024, then skyrocketed by 77bps to 20.75% in 2025.
  • The last three reported values for Gross Margin were 20.75% (Q4 2025), 20.81% (Q3 2025), and 22.59% (Q2 2025) per Business Quant data.